VS-7375 Demonstrates Robust Anti-Tumor Activity Across Advanced KRAS G12D-Mutant Cancers, Highlighted by 50% Confirmed ORR in 2L Pancreatic Ductal Adenocarcinoma and Two Complete Responses in 2L+ Dise
Go back to VS-7375 Demonstrates Robust Anti-Tumor Activity Across Advanced KRAS G12D-Mutant Cancers, Highlighted by 50% Confirmed ORR in 2L Pancreatic Ductal Adenocarcinoma and Two Complete Responses in 2L+ Dise| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 10.06 +0.85 (9.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.21 | 52 Week High | $2.43 | |||
| Open | $9.20 | 52 Week Low | $1.05 | |||
| Day High | $10.11 | P/E | N/A | |||
| Day Low | $9.14 | EPS | $-1.79 | |||
| Volume | 5,947,213 | |||||



